Concentration‐QTc Modeling of Ozanimod's Major Active Metabolites in Adult Healthy Subjects

Ozanimod, approved by regulatory agencies in multiple countries for the treatment of adults with relapsing multiple sclerosis, is a sphingosine 1‐phosphate (S1P) receptor modulator, which binds with high affinity selectively to S1P receptor subtypes 1 and 5. The relationships between plasma concentr...

Full description

Saved in:
Bibliographic Details
Main Authors: Emily Briggs (Author), Sunny Chapel (Author), Peijin Zhang (Author), Maria Palmisano (Author), Jonathan Q. Tran (Author)
Format: Book
Published: Wiley, 2021-02-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available